-
Uncategorized2 months ago
Epigenetics at Birth Links Microbiome to Neurodevelopment, Potentially ASD and ADHD
The results of a study headed by researchers at Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, indicate that the gut...
-
Uncategorized2 months ago
Plan for remade ACIP panel adds focus on vaccine safety, matching Kennedy’s push
Following a judge’s ruling that suspended most of the Trump administration’s appointments to the CDC’s vaccine advisory panel, a newly published charter for the panel will...
-
Uncategorized2 months ago
Bayer pharma executive predicts US-Europe price spreads will narrow
The price differential between the US and other countries “will be significantly narrower or smaller” going forward because of pressure from the Trump administration’s “most favored...
-
Uncategorized2 months ago
FDA rejects Replimune cancer therapy, saying company didn’t resolve trial doubts
The FDA has once again rejected Replimune’s oncolytic virus therapy to treat advanced melanoma. The Massachusetts-based drugmaker had been pushing for a reconsideration by the agency...
-
Uncategorized2 months agoFDA again spurns Replimune melanoma drug
The decision, which has been a flashpoint in an ongoing debate about regulatory flexibility, was made because Replimune failed to address the agency’s issues with the...
-
Uncategorized2 months ago
Drugs from a Text Prompt, Wegovy Pill Competition Dampens Lilly’s Surge
From designing drugs with a simple text prompt to running experiments guided by extended reality, a new wave of agentic AI is transforming the modern lab....
-
Uncategorized2 months agoGAO report shows gap between scale of illegal vapes and enforcement
With thousands of illegal e-cigarettes for sale in the U.S., both the Trump and Biden administrations have vowed to crack down on the illicit fruit- and...
-
Uncategorized2 months agoSTAT+: Replimune skin cancer drug that became FDA flashpoint is rejected again
The Food and Drug Administration on Friday rejected — again — an experimental treatment for advanced skin cancer developed by Replimune Group. Replimune’s treatment, an engineered...
-
Uncategorized2 months ago
Vivatides gets $54M; Wegovy drops cold chain in EU; Gilead takes Kymera option
New China-US biotech gets $54M: Vivatides Therapeutics raised the Series A for its preclinical-stage R&D in siRNA and antisense oligonucleotides aimed at reaching tissues beyond the...
-
Uncategorized2 months agoTrump administration admits a glaring error in its accusations about New York health care fraud
NEW YORK — President Donald Trump’s administration this week acknowledged it made a significant error in figures it used to help justify a fraud probe into New York’s...
